Tonix Pharmaceuticals Holding Corp. announced that it has entered into a securities purchase agreement with certain investors that it will issue pre-funded warrants for the gross proceeds of $30,000,000 on July 9, 2024. The Purchase Agreement contains customary representations, warranties and agreements by the Company, customary conditions to closing, indemnification obligations of the Company, other obligations of the parties, and termination provisions.